Tesla Stock Sits Nearly 30% Below Its High and Still Trades at 330 Times Earnings

Tesla shares trade around $355, ~29% below the $498.83 52-week high, but the stock still prices at ~330x trailing earnings (~$1.08/share). The article highlights weakening profitability—Q2 operating margin fell to 1.4% (from 4.1% a year earlier) and operating expenses rose 47% YoY, alongside gross margin slipping to 16.8%. While revenue grew 26% YoY to $28.2B and software/Full Self-Driving subscriptions rose 56% to 1.48M, heavy investment (capex $5.8B, up 142% YoY) drove free cash flow to -$1.1B, keeping the valuation rationale dependent on future profit acceleration.

Analysis

TSLA is still being valued as a platform with software-like margins, but the current economics look like a capital-intensive manufacturer funding optionality ahead of proof. That matters because every incremental dollar of revenue is being asked to support a much larger spend stack, so the market’s real question is whether the company can turn top-line growth into durable free cash flow before patience runs out.

Near term, the stock should trade more on narrative inflections than on fundamentals, but the asymmetry is ugly: any disappointment on margin, FCF, or monetization cadence can de-rate the multiple quickly because there is no earnings cushion. The next 1-3 months are about delivery/earnings revisions; the 6-18 month question is whether software and fleet economics can offset auto gross-margin pressure without requiring another step-up in capex.

Second-order, the clearest beneficiary of Tesla’s heavier AI spend is still the infrastructure complex, especially NVDA, because capex translates into someone else’s revenue before it translates into Tesla profits. The contrarian point is that the market may be underestimating how long optionality can keep TSLA expensive; but if that optionality remains mostly story, the stock can stay "cheap" versus its highs and still be very overvalued on cash generation.

Key Decisions for Investors

• No fresh outright long TSLA here; wait for a visible margin inflection (operating margin recovery and positive FCF) before underwriting the software multiple.
• If already long TSLA, hedge into the next 1-3 month catalyst window with a defined-risk put spread or collar; this is a valuation-compression trade, not a bankruptcy trade.
• Relative-value expression: short TSLA vs long NVDA over 6-12 months to pair unproven monetization against proven AI capex capture; thesis breaks if TSLA sustains multiple quarters of margin recovery and FCF normalization.
• Set a watch item on next earnings: if operating margin does not re-expand meaningfully or free cash flow stays negative, treat any rally as sellable.